AI assistant
Sending…
PLUS THERAPEUTICS, INC. — Director's Dealing 2022
May 19, 2022
34301_dirs_2022-05-19_a4a3f31c-9941-4a64-b80b-e4a0ee50f024.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PLUS THERAPEUTICS, INC. (PSTV)
CIK: 0001095981
Period of Report: 2022-05-17
Reporting Person: Petersen Greg (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-05-17 | Common Stock | P | 30000 | $0.55 | Acquired | 62500 | Direct |
More from PLUS THERAPEUTICS, INC.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 15
Regulatory Filings
2026
Apr 21
Regulatory Filings
2026
Apr 9
Regulatory Filings
2026
Apr 8
Regulatory Filings
2026
Mar 26
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 27
Regulatory Filings
2026
Feb 13